Taiwan's first Ocular Oncology Centre opens
Former visiting researcher Dr Honda Chou has launched Taiwan's first dedicated Ocular Oncology Centre.
Read more →Liverpool Ocular Oncology Research Group · Est. 2006
Understanding cancers of the eye. Advancing care and outcomes for patients.
We conduct high-quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours, working to improve patient care and survival across the world.
2006 Established by Prof Coupland & Prof Damato
300+ Peer-reviewed research publications
Global International research collaborations
LUMPO Prognostic tool used worldwide Our mission
Research that changes what an eye cancer diagnosis means.
Founded in 2006 by Professor Sarah Coupland and Professor Bertil Damato, the Liverpool Ocular Oncology Research Group brings together pathologists, scientists, ophthalmologists, surgeons and statisticians in one multi-disciplinary team.
Together we investigate the biology of adult ocular tumours and translate that understanding into better prognosis, vision-preserving treatments and support for patients. Our work spans the laboratory bench, the clinic and the wider community of people living with eye cancer.
One notable output is LUMPO, the Liverpool Uveal Melanoma Prognosticator Online, which predicts an individual’s risk of metastatic disease to guide surveillance and clinical trials. Read about uveal melanoma →
Disease focus & research
Where we concentrate our work
Uveal Melanoma
The most common primary intraocular cancer in adults, and the core focus of our work for over two decades.
Learn more →Conjunctival Melanoma
Rare melanoma of the ocular surface, studied through pathology and molecular profiling.
Learn more →Ocular Adnexal Lymphoma
Lymphomas of the tissues around the eye, a long-standing area of the group’s expertise.
Learn more →Molecular Pathology
Genetic and molecular analysis that turns tumour biology into prognosis and treatment.
Learn more →Ocular Oncology Biobank
A curated collection of ocular tumour samples underpinning translational research.
Learn more →EYE-CAN-AID
A Trusted Research Environment bringing data science to eye cancer safely and securely.
Learn more →For patients
You are more than your diagnosis.
Living with an eye cancer diagnosis affects far more than vision. Our team includes health psychology expertise, and we work closely with the NHS Eye Cancer Health Psychology service to support patients through diagnosis, treatment and beyond.
Find patient supportImproving patient care and survival is the reason every project in this group exists.
Latest news
From the lab and the clinic
Visit to Epredia in Runcorn
Prof Sarah Coupland, Dr Helen Kalirai and Max Jackson toured Epredia's facility to explore digital pathology partnerships.
Read more →A year of collaboration and discovery: LOORG's 2025 highlights
A look back at a year of international engagement, student mentorship, public outreach and the launch of EYE-CAN-AID.
Read more →Help us reach the next breakthrough.
Research into rare cancers relies on the generosity of supporters. Every donation funds the science that saves sight and lives.
Support our research